Noble Corporation plc vs Tempus AI — how do they compare? Noble Corporation plc trades at $42.05 (market cap $6.73B), while Tempus AI trades at $70.24 (market cap $12.58B). The key difference: Tempus AI is the larger of the two by market cap, and Noble Corporation plc pays a 4.74% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Noble Corporation plc for 26 Days and Tempus AI for 22 Days on average.
| NE | TEM | |
|---|---|---|
Market Cap | $6.73B | $12.58B |
Volume | 1,027,635 | 7,444,569 |
Sector | Energy | Broad Market / Factor |
52-Week High | $54.37 | $99.28 |
52-Week Low | $26.70 | $41.55 |
Typical Hold Time | 26 Days | 22 Days |
Enterprise Value | $8.16B | $13.21B |
Dividend Yield | 4.74% | — |
Signals from Pluang's Aura AI — not financial advice
Noble Corporation (NE) trades at $40.97, down 1.16% today, with a bearish technical outlook. The stock shows mixed earnings performance with recent misses but maintains positive cash flow. Analyst consensus is divided with a $52 price target suggesting 27% upside. Recent news includes a long-term drilling contract with Tullow in Ghana, extending utilization into 2027.
The outlook remains cautious due to ongoing legal investigations and volatile earnings. While valuation appears reasonable with EV/EBITDA of 8.79, declining revenue and profit margins pose challenges. The dividend provides income support, but investors face execution risks amid mixed analyst sentiment.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →